Aptissen SA
Sylvain D. is a seasoned finance professional with a BA in finance from ESIAE. Currently, he holds the position of Chief Financial Officer at Aptissen SA since 2023. Prior to this, he has held various key roles in companies such as Independent, Parfums M. Micallef, and CLARINS, with a focus on financial management and operations. With a wealth of experience in the field, Sylvain continues to provide his expertise through consulting and strategic financial advisory.
This person is not in any offices
Aptissen SA
Aptissen S.A. is a Swiss company specialized in the development and commercialization of biopolymer-based medical devices. Aptissen’s founders have developed for the past 25 years the best quality injectable products which meet both patients and doctors expectations: www.aptissen.com The company was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. It today distributes its products through a worldwide international distributors' network among more than 90 countries including Europe, South America, Canada, Middle East and Asia. Aptissen's team revolutionized the viscosupplement market with Synolis VA and his patented formulation which combines Hyaluronic Acid and Sorbitol. Synolis VA provides rapid mobility recovery, fast long lasting pain relief associated with excellent safety: www.synolis.com We place the patient benefit at the center of our mission to develop innovative injectable solutions based on hyaluronic acid to provide fast pain relief.